374794-92-0 Usage
Uses
Used in Pharmaceutical Applications:
1-OXA-8-AZASPIRO[4.5]DECAN-2-ONE HYDROCHLORIDE is used as a building block for the synthesis of various organic molecules in the development of new drugs. Its unique structure and versatility make it a valuable component in the creation of innovative pharmaceutical compounds.
Used in Scientific Research:
1-OXA-8-AZASPIRO[4.5]DECAN-2-ONE HYDROCHLORIDE is used as a reagent in chemical reactions for scientific research. Its properties and unique structure contribute to the advancement of knowledge in the field of chemistry and related disciplines.
Used in Drug Delivery Systems:
1-OXA-8-AZASPIRO[4.5]DECAN-2-ONE HYDROCHLORIDE may be used in the development of drug delivery systems to improve the efficacy and bioavailability of pharmaceutical compounds. Its hydrochloride salt form enhances solubility in water-based solutions, potentially facilitating the design of novel drug delivery methods.
Used in Medical Treatments:
1-OXA-8-AZASPIRO[4.5]DECAN-2-ONE HYDROCHLORIDE may have potential applications in the treatment of certain medical conditions. Further research is needed to fully understand its pharmacological effects and explore its potential as a therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 374794-92-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,4,7,9 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 374794-92:
(8*3)+(7*7)+(6*4)+(5*7)+(4*9)+(3*4)+(2*9)+(1*2)=200
200 % 10 = 0
So 374794-92-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO2.ClH/c10-7-1-2-8(11-7)3-5-9-6-4-8;/h9H,1-6H2;1H
374794-92-0Relevant articles and documents
Cyclohexane derivatives and their use as therapeutic agents
-
Page 29, (2010/02/06)
The present invention relates compounds of formula (I), wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of formulae: (a), (b), (c), (d), and (e); and R1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R17, R21a and R21b are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.
